Free forex prices, toplists, indices and lots more. GT Biopharma, Inc. Common Stock (GTBP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. GT Biopharma Inc OTC Updated May 11, 2021 10:41 PM. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Home; About. GT Biopharma (GTBP) stock price, charts, trades & the US's most popular discussion forums. The Company is engaged in discovering, developing and commercializing therapeutics from its product platform in a range of disease areas. View the latest GT Biopharma Inc. (GTBP) stock price, news, historical charts, analyst ratings and financial information from WSJ. Publications View today's stock price, news and analysis for GT Biopharma Inc. (GTBP). A high-level overview of GT Biopharma, Inc. (GTBP) stock. GTBP 15.10 0.79 (4.97%). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … GT Biopharma, Inc. (NASDAQ:GTBP) GT Biopharma, Inc., formerly OXIS International, Inc., is an immuno-oncology company. The Company develops drugs focused on the treatment of cancer. Management Team; Scientific Advisors; Our Technologies. Find real-time GTBP - GT Biopharma Inc stock quotes, company profile, news and forecasts from CNN Business. Stock quote and company snapshot for GT BIOPHARMA INC (GTBP), including profile, stock chart, recent news and events, analyst opinions, and research reports. Get GT Biopharma Inc (GTBP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Get a real-time GT Biopharma (GTBP) stock price quote with breaking news, financials, statistics, charts and more. Post-Market 0.18 (1.19%) Nasdaq: GTBP. Get the latest GT Biopharma, Inc. (GTBP) stock news and headlines to help you in your trading and investing decisions.